TickerFactsScreenerDevelopers

INTEGRATED BIOPHARMA INC (INBP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $647.0K2011: $725.0K2012: $145.0K2013: $55.0K2014: $451.0K2015: $71.0K2016: $395.0K2017: $132.0K2018: $228.0K2019: $475.0K2020: $402.0K2021: $210.0K2022: $331.0K2023: $1.32M2024: $1.68M2025: $3.62M$3.62M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.62M+115.6%
2024$1.68M+27.4%
2023$1.32M+297.6%
2022$331.0K+57.6%
2021$210.0K-47.8%
2020$402.0K-15.4%
2019$475.0K+108.3%
2018$228.0K+72.7%
2017$132.0K-66.6%
2016$395.0K+456.3%
2015$71.0K-84.3%
2014$451.0K+720.0%
2013$55.0K-62.1%
2012$145.0K-80.0%
2011$725.0K+12.1%
2010$647.0K—